
Opinion|Videos|March 31, 2025
Studying the Association Between Elevated Lp(a) Levels and Risk of Atherosclerotic Disease
Author(s)Nihar Desai, MD, MPH
Nathan Wong, PhD
Nathan Wong, PhD
Experts discuss the relationship between lipoprotein(a) (Lp[a]) levels and atherosclerotic cardiovascular disease (ASCVD) risk, with findings from a large US population study, and explore how these findings could impact clinical practice and the management of patients at risk for ASCVD.
Advertisement
Video content above is prompted by the following:
- In the introduction, I mentioned that Lp(a) is considered an independent and significant risk factor for ASCVD and aortic stenosis. Dr Wong, you recently studied the relationship between Lp(a) level and ASCVD risk in a large US population. Could you describe your findings?
- Dr Saseen, how might findings like these impact clinical practice?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Leucovorin Treatment Expansion for Autism Symptoms Under FDA Review
2
FDA Approves Imlunestrant for ER+ and HER2-Negative Breast Cancer
3
Supporting Pharmacy Residents in Completing Research Projects at UC Davis: Jeremiah J. Duby, PharmD, BCPS, BCCCP
4
Marathon Health, Medbridge Partner to Launch Integrated Virtual MSK Care Program
5